Clinical Trial Update: Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)

View source ↗

Summary

This entry describes a clinical study sponsored by Fudan University investigating ctDNA methylation as a biomarker to monitor treatment in patients with metasta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Fudan University | Conditions: Metastatic Colorectal Cancer ctDNA Surveillance | Status: RECRUITING